He's not going to talk about in vitro predictive assays again, is he?

Journal of the National Cancer Institute

Volumn 82, Issue 2, 1990, Pages 96-101

  Von Hoff, Daniel D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CHEMOSENSITIVITY; CLONOGENIC ASSAY; HUMAN; NOTE; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMAN; NEOPLASMS; PREDICTIVE VALUE OF TESTS; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR STEM CELL ASSAY;

EID: 0025062388     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/82.2.96     Document Type: Note

References (72)

1. Wright JL, Cobb JP, Gumport SL, et al: Investigation of the relation between clinical and tissue culture response to chemotherapeutic agents of human cancer. N Engl J Med 252:1207-1211, 1957
2. DiPaolo JA, Dowd JE: Evaluation of inhibition of human tumor tissue by cancer chemotherapeutic drugs with an in vitro test. J Natl Cancer Inst 27:807-815, 1961
3. Limburg H, Krabe M: Die Zuchtung von non schlichem Kreb sgewebe in der Gewebekultun und seine Sensibilitatstestung gegen neuere Zy-tostatika. Dtsch Sch Med Wochenschr 89:1938-1946, 1964
4. Dendy, PP. ed: Human Tumors in Short Term Culture: Techniques and Clinical Applications. London: Academic Press, 1976
5. Von Hoff DD, Weisenthal L: In vitro methods to predict for patient response to chemotherapy. In Advances in Pharmacology Chemotherapy (Garattini S, Gouldin A, Hawkins F, eds). New York: Academic Press, 1980, pp 133-156
6. Park CH, Bergsagel DE, McCulloch EA: Mouse myeloma tumor stem cells: A primary cell culture assay. J Natl Cancer Inst 46:411-422, 1971
7. Ogawa M, Bergsagel DE, McCulloch EA: Chemotherapy of mouse myeloma: Quantitative cell culture predictive of response in vivo. Blood 41:7-15, 1973
8. Hamburger AW, Salmon SE: Primary bioassay of human tumor stem cells. Science 197:461-463, 1977
9. Hamburger AW, Salmon SE: Primary bioassay of human myeloma stem cells. J Clin Invest 60:846-854, 1977
10. Courtenay VD, Mills J: An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer 37:261-268, 1978
11. Courtenay VD, Selby PJ, Smith IE, et al: Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer 38:77-81, 1978
12. Salmon SE, Hamburger AW, Soehnlen B, et al: Quantitations of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med 298:1321-1327, 1978
13. Sondak VK, Bertelsen CA, Tanigawa N, et al: Clinical correlations with chemosensitivities measured in a rapid thymidine incorporation assay. Cancer Res 44:1725-1728, 1984
14. Sondak VK, Korn EL, Korn DT: In vitro testing of chemotherapeutic combinations in a rapid thymidine incorporation assay. Int J Cell Cloning 6:378-391, 1988
15. Selby PJ, Steel GG: Use of the agar diffusion chamber for the exposure of human tumor cells to drugs. Cancer Res 42:4758-4762, 1982
16. Sobrero AF, Marsh JC: Chemosensitivity of human tumor clonogenic cells simultaneously assayed in agar diffusion chambers and in a two-layer agar culture system. Cancer Treat Rep 68:615-624, 1984
17. Maurer HR, Ali-Osman F: Tumor stem cell cloning in agar-containing capillaries. Naturwissenschaften 68:381-383, 1981
18. Von Hoff DD, Forseth BJ, Huong M, et al: Improved plating efficiencies for human tumors cloned in capillary tubes versus Petri dishes. Cancer Res 46:4012-4017, 1986
19. Ali-Osman F, Beltz PA: Optimization and characterizations of the capillary human tumor clonogenic cell assay. Cancer Res 48:715-724, 1988
20. Baker FL, Spitzer G, Ajani JA, et al: Drug and radiation sensitivity measurements of successful primary monolayer culturing of human tumor cells using cell-adhesive matrix and supplemental medium. Cancer Res 46:1263-1274, 1986
21. Baker FL, Ajani J, Spitzer G, et al: High colony-forming efficiency of primary human tumor cells cultured in the adhesive-tumor-cell culture system: Improvements with medium and serum alterations. Int J Cell Cloning 6:95-105, 1988
22. Daidone MG, Silvestrini R, Sanfilippo O, et al: Reliability of an in vitro short-term assay to predict the drug sensitivity of human breast cancer. Cancer 56:450-456; 1985
23. Sanfilippo O, Silvestrini R, Zaffaroni N, et al: Application of an in vitro antimetabolic assay to human germ cell testicular tumors for the preclinical evaluation of drug sensitivity. Cancer 58:1441-1447, 1986
24. Weisenthal LM, Marsden JA, Dill PL, et al: A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res 43:749-757, 1983
25. Weisenthal LM, Dill, PL, Kurnick NB, et al: Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity. Cancer Res 43:258-264, 1983
26. Bird JL, Bosanguet AG, Forskitt S, et al: Semi-micro adaptation of a 4-day differential staining cytotoxicity (DISC) assay for determining the in vitro chemosensitivity of haematological malignancies. Leuk Res 10:445-449, 1986
27. Smith HS, Lan S, Ceriani R, et al: Clonal proliferation of cultured nonmalignant and malignant human breast epithelium. Cancer Res 41:4637-4643, 1981
28. Garewal HS, Ahmann FR, Schifman RB, et al: ATP assay: Ability to distinguish cytostatic from cytocidal anticancer drug effects. JNCI 77:1039-1045, 1986
29. Freeman AE, Hoffman RM: In vivo-like growth of human tumors in vitro. Proc Natl Acad Sci USA 83:2694-2698, 1986
30. Hoffman RM, Connors KM, Meersan-Monosov AZ, et al: A general native-state method for determination of proliferation capacity of human normal and tumor tissues in vitro. Proc Natl Acad Sci USA 86:2013-2017, 1989
31. Rotman B: Fluorescent cytoprinting: A simple nondestructive process for assessing chemosensitivity in microorgan cultures. Proc Am Assoc Cancer Res 30:654-655, 1989
32. Rotman B, Teplitz C, Dickinson K: An in vitro chemosensitivity study of 128 individual human tumors. Proc Am Assoc Cancer Res 28:424, 1987
33. Dendy PP, Hill BT, eds: Human Tumors Drug Sensitivity Testing In Vitro: Techniques and Clinical Applications. New York: Academic Press, 1983
34. Salmon SE, ed: Cloning of Human Tumor Stem Cells. New York: Alan R. Liss, 1980
35. Salmon SE, Trent JM, eds: Human Tumor Cloning. Orlando: Grune & Stratton, 1984
36. Selby P, Buick RN, Tannock I: A critical appraisal of the “human tumor stem-cell assay.” N Engl J Med 308:129-134, 1983
37. Von Hoff DD: In vitro predictive testing: The sulfonamide era. Int J Cell Cloning 5:179-190, 1987
38. Von Hoff DD: Human tumor cloning assays: Applications in clinical oncology and new antineoplastic agent development. Cancer Metastasis Rev 7:357-371, 1988
39. McGuire WL, Kern DH, Von Hoff DD, et al: In vitro assays to predict drug sensitivity and drug resistance. Breast Cancer Res Treat 12:7-21, 1988
40. Von Hoff DD, Forseth B, Gonzales L: Culture and sensitivity testing of tumors. Tex Med 82:32-35, 1986
41. Grosh WW, Von Hoff DD: The human tumor clonogenic assay and other cell culture techniques: Potential applications to the study of undifferentiated neoplasms or cancer of unknown origin. In Poorly Differentiated Neoplasms and Tumors of Unknown Origin (Fer MF, Grade A, Oldham RK, eds). Orlando: Grune & Stratton, 1986, pp 451-477
42. Weisenthal LM, Lippman ME: Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treat Rep 69:615-632, 1985
43. Hanauske AR, Hanauske U, Von Hoff DD: The human tumor cloning assay in cancer research and therapy. Curr Probl Cancer 9:4-50, 1985
44. Hamburger AW: The human tumor clonogenic assay as a model system in cell biology. Int J Cell Cloning 5:89-107, 1987
45. Dittrich CH: Klonieren Von Soliden Tumoren. Vienna, New York: Springer-Verlag, 1987, pp 1-171
46. Salmon SE: Human tumor colony assay and chemosensitivity testing. Cancer Treat Rep 68:117-125, 1984
47. Ajani JA, Sahu SK, Spitzer G, et al: Cloning of human tumor stem cells in soft agar—an overview. Cancer Bull 35:16-19, 1983
48. Von Hoff DD: “Send this patient’s tumor for culture and sensitivity.” N Engl J Med 308:154-155, 1983
49. Bradley EG, Issell BF, Hellman R: The human tumor colony-forming chemosensitivity assay: A biological and clinical review. Invest New Drugs 2:59-70, 1984
50. Singletary SE, Umbach GE, Spitzer G, et al: The human tumor stem cell assay revisited. Int J Cell Cloning 3:116-128, 1985
51. Leiber MM, Kovach JS: Soft agar colony formation assay for chemotherapy sensitivity testing of human solid tumors. Mayo Clin Proc 57:527-528, 1982
52. Mattern J, Volm M: Clinical relevance of predictive tests for cancer chemotherapy. Cancer Treat Rev 9:267-298, 1982
53. Hug V, Thames H, Johnston D, et al: The true predictive value of the human tumor stem cell assay: Does a workable assay select for treatment responders? J Clin Oncol 2:42-45, 1984
54. Korn EL, Sondak VK, Bertelsen CA, et al: Analysis of the clinical utility of a predictive chemosensitivity assay. Stat Med 4:527-534, 1985
55. Welander CE, Homesley HD, Jobson VW: In vitro chemotherapy testing of gynecologic tumors: Basis for planning therapy? Am J Obstet Gynecol 147:188-195, 1983
56. Lieber MM: Technical problems with soft agar colony formation assays for in vitro chemosensitivity testing of human solid tumors: Mayo Clinic experience. Recent Results Cancer Res 94:51-55, 1984
57. Salmon SE: Improved methodology for chemosensitivity testing? J Clin Oncol 5:1861-1863, 1987
58. Batist G, Carney DN, Cowan KH, et al: Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer Clinical trial and in vitro correlates. J Clin Oncol 4:982-986, 1986
59. Rozencweig M, Staquet M: Predictive tests for the response to cancer chemotherapy: Limitations related to the prediction of rare events. Cancer Treat Rep 68:611-613, 1984
60. Von Hoff DD, Sandbach JF, Clark GM: Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. J Nad Cancer Inst 82:110-116, 1990
61. Park CH, Wiernik PH, Morrison FS, et al: Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs. Cancer Res 43:2346-2349, 1983
62. Park CH, Amare M, Morrison FS, et al: Chemotherapy sensitivity assessment of leukemic colony-forming cells with in vitro simultaneous exposure to multiple drugs: Clinical correlations in acute nonlym-phocytic leukemia. Cancer Treat Rep 66:1257-1261, 1982
63. Hamburger AW, Salmon SE, Kim MB, et al: Direct cloning of human ovarian carcinoma cells in agar. Cancer Res 38:3438-3444, 1978
64. Head JF, Allen PJ, Birch B, et al: Evaluation of the adhesive tumor cell culture system (ATCCS) chemosensitivity (CS) assay by the National Biotherapy Study Group (NBSG). Proc ASCO 8:56, 1989
65. Wittliff JL, Day TG, Dean WL, et al: Identifications of endocrine responsive breast and endometrial carcinoma using steroid receptors. In Prediction of Response to Cancer Therapy (Hall TC, ed). New York: Alan R. Liss, 1988, pp 11-41
66. Sanders WE Jr, Sanders CC: Do in vitro antimicrobial susceptibility tests accurately predict therapeutic responsiveness in infected patients? In Significance of Medical Microbiology in the Care of Patients (Victor L, ed). Baltimore: Williams & Wilkins, 1982, pp 305-340
67. Tisman C, Wa SJC: The “clonogenic cluster”: An interesting laboratory observation. Proc Am Assoc Cancer Res and ASCO 22:236, 1981
68. Shoemaker RH, Wolpert-Defilippes MK, Kern DH, et al: Application of a human tumor colony-forming assay to new drug screening. Cancer Res 45:2145-2153, 1985
69. Hanauske U, Hanauske AR, Marshall MH, et al: Biphasic effect of vanadium salts on in vitro tumor colony growth. Int J Cell Cloning 5:170-178, 1987
70. Alberts DS, Chen HSG, Salmon SE: In vitro drug assay: Pharmaco-logic considerations. In Cloning of Human Tumor Stem Cells (Salmon SE, ed). New York: Alan R. Liss, 1980, pp 197-207
71. Ali-Osman F, Giblin J, Dougherty D, et al: Application of in vivo and in vitro pharmacokinetics for physiologically relevant drug exposure in a human tumor clonogenic cell assay. Cancer Res 47:3718-3724, 1987
72. Welander CE, Morgan TM, Homesley HD: Multiple factors predicting responders to combination chemotherapy in patients with ovarian cancer. In Human Tumor Cloning (Salmon SE, Trent JM, eds). Orlando: Grune & Stratton, 1984, pp 521-534